• Home
  • About Journal
    Journal Introduction
    Editorial Board
    Youth Editorial Board
    Cooperating Institutions
    Editorial Department
  • Submission Guidelines
  • Policies & Statements
    Ethical Guidelines for Publication
    Academic Misconduct Statement
    Open Access (OA) Statement
    AIGC Use Statement
  • Journal Subscription
  • Download Center
  • 中文版
Cite this article:
DING Xiaoli,LI Mengjiao,TAN Liyuan,YAO Shangchen,CHEN Hua,SUN Huimin.Overview and reflections on the drug registration management systems of China, the United States, Japan and European Union[J].Journal Of Pharmaceutical Research,2025,44(12):1188-1193[Click to copy]
【Print this page】      【Download PDF Full Text】   【View/Add Comment】  【Download reader】  【 Close 】
←Previous|Next→ Archive    Advanced Search
This article has been viewed: 2212times   Download 796次 QR Code for this article
Scan with your phone!
中美日欧药品注册管理制度概述及思考
丁晓丽,李梦娇,谭丽媛,姚尚辰,陈华,孙会敏
Font:Larger+|Default|Smaller-
(中国食品药品检定研究院,国家药品监督管理局化学药品质量研究与评价重点实验室,北京 102629)
摘要:
目的 为优化完善我国药品注册管理制度提供国际化参考。方法 通过系统总结中国、美国、日本及欧洲药品注册管理制度(监管机构、法律法规及注册程序),对比分析其差异。结果 我国药品注册管理制度在法律法规、审评审批流程及效率、药品监管国际协调等方面还有待于进一步发展提高。结论 全球药品监管呈现科学化、国际化、效率化的发展趋势,建议我国借鉴国际上先进的管理经验,构建更高效权威的药品注册管理制度,为保障公众健康权益和推动医药产业高质量发展提供制度支撑。
关键词:  药品注册  监管机构  法律法规  注册程序  高效权威  高质量发展
DOI:10.13506/j.cnki.jpr.2025.12.007
基金项目:
Publication Date:December 25, 2025
Overview and reflections on the drug registration management systems of China, the United States, Japan and European Union
DING Xiaoli,LI Mengjiao,TAN Liyuan,YAO Shangchen,CHEN Hua,SUN Huimin
(National Institutes for Food and Drug Control, NMPA Key Laboratory for Quality Research and Evaluation of Chemical Drugs, Beijing 102629, China)
Abstract:
Objective To provide international references for optimizing and improving the drug registration management system of China. Methods The drug registration management systems of China,the United States,Japan and the European Union,were summarized and analyzed systematically, including the regulatory authorities,law and regulations and registration procedures. Results The drug registration management system of China should be implemented in terms of law and regulations、review and approved process and efficiency, inernational coordination. Conclusion Global drug regulation is showing a trend of scientific, international and efficient development. It is suggested that China should build a more efficient and authoritative drug registration management by drawing on the international management experience.which can provide institutional support for safeguarding public health rights and high-quality development of the pharmaceutical industry.
Key words:  Drug registration  Regulatory authorities  Law and regulations  Registration procedure  Efficient and authority  High-quality development
Today's Visits:511    Total Visits:2383242
Website copyright:Editorial Board of Journal of Pharmaceutical Research     鲁ICP备17018036号-3     鲁公网安备 37010202001351号
Sponsored by:Shandong Institute for Food and Drug Control Shandong Pharmaceutical Association Address:No.2749 Xinluo Street,High-Tech Zone,Jinan,P.R.China Postcode:250101
Telephone Number:0531-81216586 Email :yaoxueyanjiu@163.com;yaoxueyanjiu@126.com
Technical Support:Beijing Qinyun Technology Co., Ltd.